CollPlant Biotechnologies (CLGN) holders buy 1,764,706 shares plus new warrants

A Loewenbaum-led investor group and related entities have reported a combined beneficial holding of 3,518,237 Ordinary Shares in CollPlant Biotechnologies (CLGN), representing 18.6% of outstanding shares. The Loewenbaum 1992 Trust recently purchased 1,764,706 Ordinary Shares along with Series A and Series B Warrants. These warrants, with an exercise price of $0.34 per share, will become exercisable after anticipated shareholder approval around July 29, 2026, and expire in 2028 and 2031, respectively.